TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Nec Oncoimmunity AS
Closing information (x1000 SEK)
| Closing information | 2023/03 | 2022/03 | 2021/03 |
| Turnover |
3,208
|
2,565
|
7,498 |
| Financial expenses |
2,392
|
880
|
952 |
| Earnings before taxes |
-36,228
|
-26,037
|
-21,780 |
| Total assets |
72,712
|
142,196
|
38,831 |
| Current assets |
65,001
|
131,988
|
38,574 |
| Current liabilities |
12,329
|
37,886
|
17,065 |
| Equity capital |
60,383
|
104,312
|
21,766 |
| - share capital |
350
|
305
|
291 |
| Employees (average) | 18 | 16 |
Financial ratios
| Fiscal year | 2023/03 | 2022/03 | 2021/03 |
| Solvency |
83.0%
|
73.4%
|
56.1% |
| Turnover per employee | 178 | 469 | |
| Profit as a percentage of turnover |
-1129.3%
|
-1015.1%
|
-290.5% |
| Return on assets (ROA) |
-46.5%
|
-17.7%
|
-53.6% |
| Current ratio |
527.2%
|
348.4%
|
226.0% |
| Return on equity (ROE) |
-60.0%
|
-25.0%
|
-100.1% |
| Change turnover |
832
|
-5,313
|
-8,524 |
| Change turnover % |
35%
|
-67%
|
-53% |
| Chg. No. of employees | 1 | ||
| Chg. No. of employees % | 7% |
Total value of public sale
| Fiscal year | 2023/03 | 2022/03 | 2021/03 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.